6 results
8-K
EX-99.1
DMAC
DiaMedica Therapeutics Inc.
6 Jul 22
DiaMedica Therapeutics Announces Clinical Hold of its Phase 2/3 ReMEDy2 Clinical Trial for DM199
4:30pm
the patients then recovered within minutes and suffered no injuries. We are committed to working diligently with the FDA to resolve this issue and resume
8-K
EX-10.1
DMAC
DiaMedica Therapeutics Inc.
29 Jun 22
Entry into a Material Definitive Agreement
4:30pm
will be liable for all damage or injuries sustained by other tenants or occupants of the Building or Landlord resulting from Tenant’s carelessness
S-1
EX-10.8
DMAC
DiaMedica Therapeutics Inc.
9 Nov 18
IPO registration
4:21pm
as to prevent waste or damage. Tenant will be liable for all damage or injuries sustained by other tenants or occupants of the Building or Landlord resulting
DRS
EX-10.8
jtvbsvxg
1 Nov 18
Draft registration statement
12:00am
- Prev
- 1
- Next